Latest Dilution News

Empire Resources has successfully raised A$5 million through a two-tranche placement to accelerate exploration at its Yuinmery and Penny’s projects, with strong backing from existing and new investors.

Cobre Limited has voluntarily suspended its ASX trading to finalise details of a significant acquisition and placement, with an announcement expected imminently.

BKI Investment Company has appointed Morgans Financial to conduct on-market share purchases to fulfill its Dividend Reinvestment Plan obligations, aiming to avoid dilution by pricing shares at no discount.

Revolution Private Credit Income Trust has successfully raised $60 million through a wholesale placement, strengthening its capacity to invest in senior secured loans and asset-backed securities across Australia and New Zealand.

Cyclopharm Limited has completed the initial phase of a $14 million share placement, issuing nearly 9.5 million shares at 95 cents each, with the remaining shares set for issuance later this month.

Humm Group Limited reported a $13.9 million statutory profit for the half-year ended December 2025, despite increased credit losses and elevated costs. The company’s ongoing transformation and global expansion underpin cautious optimism for the year ahead.

Ionic Rare Earths is advancing its rare earth magnet recycling ambitions with strategic leadership relocation, government recognition, and new funding discussions. The company’s Belfast facility gains global significance as it targets key international markets.

Evolution Mining Limited has announced a fully franked ordinary dividend of AUD 0.20 per share for the half-year ending December 2025, accompanied by a Dividend Reinvestment Plan with no discount.

Evolution Mining has secured a significant capital injection and reduced streaming rates in a revamped agreement with Triple Flag, paving the way for development of the gold-rich E44 deposit at Northparkes.

Evolution Energy Minerals Limited has announced a renounceable pro-rata entitlement offer to raise up to $4.03 million, aiming to fund exploration and development of its Tanzanian copper and graphite assets. The offer includes free attaching options and is partially underwritten, reflecting both opportunity and risk amid regulatory challenges.

Evolution Energy Minerals has announced a $4 million renounceable entitlement offer priced at 1.5 cents per share, including free attaching options, with major shareholder Metals One Plc committing $1 million.

Argenica Therapeutics has reported a significant increase in its half-year loss to $3.82 million, driven by reduced revenue and higher research and development expenses. The company continues to invest heavily in its neuroprotective drug candidate ARG-007 amid ongoing clinical trials.